ChemoSen Cancer Research Results

ChemoSen, chemo-sensitization: Click to Expand ⟱
Source:
Type:
The effectiveness of chemotherapy by increasing cancer cell sensitivity to the drugs used to treat them, which is known as “chemo-sensitization”.

Possible Chemo-Sensitizers:
-Curcumin
-Resveratrol
-EGCG
-Quercetin
-Genistein
-Berberine
-Piperine: alkaloid from black pepper
-Ginsenosides: active components of ginseng
-Silymarin
-Allicin
-Lycopene
-Ellagic acid
-Caffeic acid phenethyl ester
-flavopiridol
-oleandrin
-Ursolic acid
-butein
-Betulinic acid
Scientific Papers found: Click to Expand⟱
8336- LDN,    Low-dose naltrexone suppresses ovarian cancer and exhibits enhanced inhibition in combination with cisplatin
- in-vivo, Ovarian, NA
Dose↝, ChemoSen↑, Weight↑, OGF↑, OGFr↑,
8341- LDN,    Low-Dose Naltrexone as an Adjuvant in Combined Anticancer Therapy
- Review, Var, NA
OGFr↑, TumCP↓, TumCCA↑, Apoptosis↑, toxicity↝, Half-Life↝, *FasL↓, *Fas↓, BAX↑, Casp9↑, Casp3↑, Bcl-2↓, survivin↓, PI3K↓, PDK1 / PDPK1↓, mTOR↓, ChemoSen↑, chemoP↑, Synergy↑, QoL∅,
8338- LDN,    Low-dose naltrexone plays antineoplastic role in cervical cancer progression through suppressing PI3K/AKT/mTOR pathway
- vitro+vivo, Cerv, HeLa - in-vitro, Cerv, SiHa
TumCP↓, TumCMig↓, TumCI↓, PI3K↓, p‑Akt↓, mTOR↓, OGFr↑, Dose↝, *toxicity↝, chemoP↑, ChemoSen↑,
8340- LDN,    Naltrexone at low doses upregulates a unique gene expression not seen with normal doses: Implications for its use in cancer therapy
- in-vitro, CRC, HCT116
BAD↑, eff↑, ChemoSen↑, eff↑,
8276- LE,  Cisplatin,    Glycyrrhizin enhances the antitumor activity of cisplatin in non‑small cell lung cancer cells by influencing DNA damage and apoptosis
- in-vitro, NSCLC, NA
tumCV↓, ChemoSen↑, Apoptosis↑, TumCCA↑, Bcl-xL↑, cl‑Casp↑, γH2AX↑, P53↑,
8278- LE,    Glycyrrhiza glabra (Licorice): A Comprehensive Review on Its Phytochemistry, Biological Activities, Clinical Evidence and Toxicology
- Review, Var, NA
*Ingr↝, *AntiCan↑, *AntiDiabetic↑, *AntiBio↑, *Inflam↓, *antiAll↑, *hepatoP↑, *cough?, *SoreThr?, *toxicity↝, *cardioP↑, *BioAv↝, *PGE2↓, *COX2/PTGS2↓, *AntiAg↑, *ROS↓, *NLRP3↓, *NF-kB↓, *AP-1↓, TumCCA↑, Apoptosis↑, TumMeta↑, *Dose↝, *Dose↝, Ingr↝, TumAuto↑, LC3II↑, PI3K↓, Akt↓, mTOR↓, *cognitive↑, *BloodF↑, ChemoSen↑, ROS↓, *chemoP↑, ROS↑, tumCV↓, MMP↓, *AntiBio↑, *toxicity↝,
8135- LF,    Lactoferrin-A Regulator of Iron Homeostasis and Its Implications in Cancer
- Review, Var, NA - Review, AD, NA
IronCh↑, ROS↓, Imm↑, Inflam↓, *BBB↑, Iron↝, *Fenton↓, *ROS↓, *TAC↑, *SOD↑, *GPx↑, *GSH↑, *TBARS↓, *PTEN↓, *tau↓, *MAPK↓, *Aβ42↓, *Apoptosis↓, *Casp3↓, *Akt↑, *GutMicro↑, *Sepsis↓, *anemia↓, *IL6↓, *FPN↑, *TfR1/CD71↑, *Ferritin↓, *HemoG↑, *RBC↑, *eff↑, *BioAv↓, *BioAv↑, *BioAv↝, *ChemoSen↑, *BioAv↑, Ferroptosis↑,
8190- LGE,  doxoR,    Cymbopogon citratus and Citral Overcome Doxorubicin Resistance in Cancer Cells via Modulating the Drug's Metabolism, Toxicity, and Multidrug Transporters
- in-vitro, BC, MCF7 - in-vitro, Liver, HepG2 - in-vitro, Ovarian, SKOV3
ChemoSen↑, CYP3A4↓, PXR, NR1I2↓, GSTA1↓, MDR1↓, MRP1/ABCC1↓, ABCG2↓,
8292- lign,    Anticancer potential of flaxseed lignans, their metabolites and synthetic counterparts in relation with molecular targets: current challenges and future perspectives
- Review, Var, NA
*BioAv↝, chemoPv↑, Apoptosis↑, TumCP↓, TumMeta↓, angioG↓, *AntiDiabetic↑, *antiOx↑, *AntiCan↑, *Inflam↓, *cardioP↑, TumCCA↑, PSA↓, miR-106b↓, IGF-1↓, ERK↓, Akt↓, Bcl-2↓, p‑FAK↓, radioP↑, P-gp/ABCB1↓, ChemoSen↑, MMP↓, ROS↑, BioAv↓, *toxicity↓, chemoP↑,
8295- lign,    Distribution, biosynthesis and therapeutic potential of lignans
- Review, Var, NA
*Ingr?, *BioAv↝, *antiOx↑, *AntiCan↑, *Inflam↓, *other?, Dose↝, AntiTum↑, pS2/TFF1↓, Bcl-2↓, IGF-1R↓, *radioP↑, *HO-1↑, GSTM1↑, NQO1↑, ChemoSen↑, *AntiDiabetic↑, *glucose↓, *GSH↑, *SOD↑, *MDA↓, *NO↓, *Bacteria↓, *AntiFungal↑,
8327- LIN,    Recent updates on bioactive properties of linalool
- Review, Var, NA
*AntiCan↑, *AntiBio↑, *neuroP↑, *Stress↓, *hepatoP↑, *RenoP↑, *ROS↓, ROS↑, *Inflam↓, *toxicity↓, TumCP↓, TumCCA↑, mtDam↑, MMP↓, compI↓, compII↓, ETC↓, ATP↓, angioG↓, ChemoSen↑, *GSH↑, *MDA↓, *lipid-P↓, *NRF2↑, *HO-1↑, *ALAT↓, *AST↓, chemoP↑,
8323- LIN,  doxoR,    Efficacy of Combination Therapy with Linalool and Doxorubicin Encapsulated by Liposomes as a Two-in-One Hybrid Carrier System for Epithelial Ovarian Carcinoma
- vitro+vivo, Ovarian, NA
ChemoSen↑, TumCG↓, Ki-67↓, CD31/PECAM-1↓, Casp3↑, *toxicity↓, chemoP↑, *BioAv↓, EPR↑,
8322- LIN,  doxoR,    Effect of linalool as a component of Humulus lupulus on doxorubicin-induced antitumor activity
- vitro+vivo, Var, NA
ChemoSen↑, TumW↓, Na+↝,
8321- LIN,  doxoR,    Linalool, a plant-derived monoterpene alcohol, reverses doxorubicin resistance in human breast adenocarcinoma cells
- in-vitro, BC, MCF7
ChemoSen↑, EPR↑, Bcl-xL↓, P-gp/ABCB1↓, TumCCA⇅, tumCV↓, Apoptosis↑,
8320- LIN,    Ameliorative Effect of Linalool in Cisplatin-Induced Nephrotoxicity: The Role of HMGB1/TLR4/NF-κB and Nrf2/HO1 Pathways
- in-vivo, Nor, NA
RenoP↑, Dose↝, *TLR4↓, *MyD88↓, *TRIF↓, *TNF-α↓, *IL1β↓, *IL6↓, *NF-kB↓, *chemoP↑, *Casp3↓, *Casp9↓, *BAX↓, *Bcl-2↑, ChemoSen↑, *cardioP?, *hepatoP↑, *Apoptosis↓, *antiOx↑, *Inflam↓, *ROS↓, *BUN?, *creat↓, *GSH↑, *SOD↑, *Catalase↑, *MDA↓, *NADPH↓, *NRF2↑, *HO-1↑,
6483- LIN,    Linalool-Incorporated Nanoparticles as a Novel Anticancer Agent for Epithelial Ovarian Carcinoma
- in-vitro, Ovarian, A2780S
Apoptosis↑, ROS↑, MMP↓, Casp3↑, TumW↓, ChemoSen↑, EPR↑,
8375- LT,    Luteolin, a flavone ingredient: Anticancer mechanisms, combined medication strategy, pharmacokinetics, clinical trials, and pharmaceutical researches
- Review, Var, NA
TumCP↓, TumCI↓, Apoptosis↑, TumCCA↑, Inflam↓, Ferroptosis↑, Pyro↑, ChemoSen↑, chemoP↑, *BioAv↓, OATPs↓,
8395- LT,  PacT,    Luteolin enhances drug chemosensitivity by downregulating the FAK/PI3K/AKT pathway in paclitaxel‑resistant esophageal squamous cell carcinoma
- in-vitro, ESCC, NA
*AntiTum↑, TumCP↓, TumCCA↑, Apoptosis↑, TumCMig↓, EMT↓, ChemoSen↑, PI3K↓, Akt↓, FAK↓,
8376- LT,  Cisplatin,    Luteolin sensitizes the anticancer effect of cisplatin via c-Jun NH2-terminal kinase-mediated p53 phosphorylation and stabilization
- vitro+vivo, Var, NA
ChemoSen↑, JNK↑, P53↑,
8384- LT,    Current situation and research progress of luteolin in the treatment of gastrointestinal malignant tumors
- Review, GC, NA
Apoptosis↑, TumAuto↑, TumCCA↑, EMT↓, *ROS↓, *antiOx↑, ROS↑, P53↑, LC3II↑, Beclin-1/ATG6↑, p‑MAP2K1/MEK1↓, p‑ERK↓, BAX↑, cl‑Casp3↑, Bcl-2↓, p‑MAPK↓, DNArepair↓, HMGB1↓, XRCC1↓, ERCC3↑, CycB/CCNB1↓, CDC2↓, p‑CHK1↑, TumCCA↑, TumCP?, Wnt↓, β-catenin/ZEB1↓, miR-384↑, PTN↓, MMP2↓, MMP3↓, MMP9↓, MMP16↓, Ferroptosis↑, GPx4↓, Synergy↑, Ki-67↓, GSH↓, ChemoSen↑, TumCP↓, TumCMig↓, TumCI↓, PI3K↓, Akt↓, mTOR↓, NF-kB↓, NOTCH↓, miR-139-5p↑, miR-34a↑, miR-422a↑, miR-107↑, miR-21↓, miR-155↓, miR-224↓, miR-340↓, E-cadherin↑, N-cadherin↓, Vim↓, HK1↓, FOXO1↓, compI↓, compIII↓, compV↓, ETC↓, BioAv↝,
8386- LT,    Luteolin induces apoptosis in Philadelphia chromosome-positive acute lymphoblastic leukemia cell by regulating the PI3K/AKT signaling pathway
- in-vitro, ALL, SUP-B15
tumCV↓, ROS↑, MMP↓, ATP↓, p‑PI3K↓, p‑Akt↓, p‑STAT3↓, Bcl-2↓, BAX↑, cl‑Casp3↑, cl‑Casp9↑, TumCP↓, eff↓, ChemoSen↑, FAK↓, Synergy↑, BioAv↓, BioAv↑,
8393- LT,    Progress, pharmacokinetics and future perspectives of luteolin modulating signaling pathways to exert anticancer effects: A review
- Review, Var, NA
TumCP↓, TumMeta↓, angioG↓, EMT↓, Imm↝, ChemoSen↑, *Inflam↓, *COX2/PTGS2↓, *NF-kB↓, MMP2↓, MMP9↓, p‑Akt↓, p‑PI3K↓, IGF-2↓, IGF-1R↓, CXCL16↓, NOTCH1↓, HES1↓, VEGF↓, ROS↑,
8406- LT,  Cisplatin,    Luteolin sensitizes the anticancer effect of cisplatin via c-Jun NH2-terminal kinase–mediated p53 phosphorylation and stabilization
- vitro+vivo, Liver, HepG2 - in-vitro, Laryn, HEp2
ChemoSen↑, Dose↝, P53↑,
1060- LT,  BTZ,    Luteolin inhibits the TGF-β signaling pathway to overcome bortezomib resistance in multiple myeloma
- vitro+vivo, Melanoma, NA
ALDH1A1↓, TGF-β↓, ChemoSen↑,
2589- LT,  Chemo,    Luteolin Inhibits Breast Cancer Stemness and Enhances Chemosensitivity through the Nrf2-Mediated Pathway
- in-vitro, BC, MDA-MB-231
NRF2↓, HO-1↓, ChemoSen↑, CSCs↓, SIRT1↓,
2588- LT,  Chemo,    Luteolin sensitizes two oxaliplatin-resistant colorectal cancer cell lines to chemotherapeutic drugs via inhibition of the Nrf2 pathway
- in-vitro, CRC, HCT116
NRF2↓, NQO1↓, HO-1↓, GSH↓, ChemoSen↑,
2587- LT,    Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs
- in-vitro, Lung, A549
NRF2↓, GSH↓, ChemoSen↑, HO-1↓,
2914- LT,    Therapeutic Potential of Luteolin on Cancer
- Review, Var, NA
*antiOx↑, *IronCh↑, *toxicity↓, *BioAv↓, *BioAv↑, DNAdam↑, TumCP↓, DR5↑, P53↑, JNK↑, BAX↑, cl‑Casp3↑, cl‑Casp8↑, cl‑Casp9↑, cl‑PARP↑, survivin↓, cycD1/CCND1↓, CycB/CCNB1↓, CDC2↓, P21↑, angioG↓, MMP2↓, AEG1↓, VEGF↓, VEGFR2/KDR/Flk1↓, MMP9↓, CXCR4↓, PI3K↓, Akt↓, ERK↓, TumAuto↑, LC3B-II↑, EMT↓, E-cadherin↑, N-cadherin↓, Wnt↓, ROS↑, NICD↓, p‑GSK‐3β↓, iNOS↓, COX2/PTGS2↓, NRF2↑, Ca+2↑, ChemoSen↑, ChemoSen↓, IFN-γ↓, RadioS↑, MDM2↓, NOTCH1↓, AR↓, TIMP1↑, TIMP2↑, ER Stress↑, CDK2↓, Telomerase↓, p‑NF-kB↑, p‑cMyc↑, hTERT/TERT↓, RAS↓, YAP/TEAD↓, TAZ↓, NF-kB↓, NRF2↓, HO-1↓, MDR1↓,
2919- LT,    Luteolin as a potential therapeutic candidate for lung cancer: Emerging preclinical evidence
- Review, Var, NA
RadioS↑, ChemoSen↑, chemoP↑, *lipid-P↓, *Catalase↑, *SOD↑, *GPx↑, *GSTs↑, *GSH↑, *TNF-α↓, *IL1β↓, *Casp3↓, *IL10↑, NRF2↓, HO-1↓, NQO1↓, GSH↓, MET↓, p‑MET↓, p‑Akt↓, HGF/c-Met↓, NF-kB↓, Bcl-2↓, SOD2↓, Casp8↑, Casp3↑, PARP↑, MAPK↓, NLRP3↓, ASC↓, Casp1↓, IL6↓, IKKα↓, p‑p65↓, p‑p38↑, MMP2↓, ICAM-1↓, EGFR↑, p‑PI3K↓, E-cadherin↓, ZO-1↑, N-cadherin↓, CLDN1↓, β-catenin/ZEB1↓, Snail↓, Vim↑, ITGB1↓, FAK↓, p‑Src↓, Rac1↓, Cdc42↓, Rho↓, PCNA↓, Tyro3↓, AXL↓, CEA↓, NSE↓, SOD↓, Catalase↓, GPx↓, GSR↓, GSTs↓, GSH↓, VitE↓, VitC↓, CYP1A1↓, cFos↑, AR↓, AIF↑, p‑STAT6↓, p‑MDM2↓, NOTCH1↓, VEGF↓, H3↓, H4↓, HDAC↓, SIRT1↓, ROS↑, DR5↑, Cyt‑c↑, p‑JNK↑, PTEN↓, mTOR↓, CD34↓, FasL↑, Fas↑, XIAP↓, p‑eIF2α↑, CHOP/DDIT3↑, LC3II↑, PD-1↓, STAT3↓, IL2↑, EMT↓, cachexia↓, BioAv↑, *Half-Life↝, *eff↑,
2916- LT,    Antioxidative and Anticancer Potential of Luteolin: A Comprehensive Approach Against Wide Range of Human Malignancies
- Review, Var, NA - Review, AD, NA - Review, Park, NA
proCasp9↓, CDC2↓, CycB/CCNB1↓, Casp9↑, Casp3↑, Cyt‑c↑, cycA1/CCNA1↑, CDK2↓, APAF1↑, TumCCA↑, P53↑, BAX↑, VEGF↓, Bcl-2↓, Apoptosis↑, p‑Akt↓, p‑EGFR↓, p‑ERK↓, p‑STAT3↓, cardioP↑, Catalase↓, SOD↓, *BioAv↓, *antiOx↑, *ROS↓, *NO↓, *GSTs↑, *GSR↑, *SOD↑, *Catalase↑, *lipid-P↓, PI3K↓, Akt↓, CDK2↓, BNIP3↑, hTERT/TERT↓, DR5↑, Beclin-1/ATG6↑, TNF-α↓, NF-kB↓, IL1↓, IL6↓, EMT↓, FAK↓, E-cadherin↑, MDM2↓, NOTCH↓, MAPK↑, Vim↓, N-cadherin↓, Snail↓, MMP2↓, Twist↓, MMP9↓, ROS↑, MMP↓, *AChE↓, *MMP↑, *Aβ↓, *neuroP↑, Trx1↑, ROS↓, *NRF2↑, NRF2↓, *BBB↑, ChemoSen↑, GutMicro↑, *antiAll↑, *Mucositis↓, *TregCell↑, *Beclin-1/ATG6↓, *PI3K↑, *Akt↑, *mTOR↑,
8347- Lut,    Carotenoid Lutein Selectively Inhibits Breast Cancer Cell Growth and Potentiates the Effect of Chemotherapeutic Agents through ROS-Mediated Mechanisms
- in-vitro, BC, NA
TumCG↓, TumCCA↑, selectivity↑, ROS↑, eff↓, P53↑, HSP60/HSPD1↑, cycF↑, CDC25↑, CDK6↑, ANAPC2↑, AURKB↑, GADD45A↑, BAX↑, Casp3↑, CASP4↑, Casp8↑, TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, DR6↑, ChemoSen↑,
8342- Lut,  Cisplatin,    Lutein Influences Cisplatin Sensitivity Through Differential Regulation of DNA Damage Response Genes in Breast Cancer Cells
- in-vitro, Nor, HUVECs - in-vitro, BC, MDA-MB-231 - in-vitro, BC, MCF7
tumCV↓, DNAdam↑, selectivity↑, ROS↑, Casp3↑, BRCA1↓, Ku70/XRCC6↓, XRCC1↓, ChemoSen↑, NA↓,
3273- Lyco,    Lycopene
- Review, Var, NA
antiOx↑, ChemoSen↓, RadioS↓,
3277- Lyco,    Recent trends and advances in the epidemiology, synergism, and delivery system of lycopene as an anti-cancer agent
- Review, Var, NA
antiOx↑, TumCP↓, Apoptosis↑, TumMeta↑, ChemoSen↑, BioAv↓, Dose↝, BioAv↓, BioAv↑, SOD↑, Catalase↑, GPx↑, IL2↑, IL4↑, IL1↑, TNF-α↑, GSH↑, GPx↑, GSTA1↑, GSR↑, PPARγ↑, Casp3↑, NF-kB↓, COX2/PTGS2↓, Bcl-2↑, BAX↓, P53↓, CHK1↓, Chk2↓, γH2AX↓, DNAdam↓, ROS↓, P21↑, PCNA↓, β-catenin/ZEB1↓, PGE2↓, ERK↓, cMyc↓, cycE/CCNE↓, JAK1↓, STAT3↓, SIRT1↑, cl‑PARP↑, cycD1/CCND1↓, TNF-α↓, IL6↓, p65↓, MMP2↓, MMP9↓, Wnt↓,
1708- Lyco,    The Anti-Cancer Activity of Lycopene: A Systematic Review of Human and Animal Studies
- Review, Var, NA
OS↑, ChemoSen↑, QoL↑, PSA∅, Synergy↑, AntiCan↑, AntiCan↑, angioG↓, VEGF↓, Hif1a↓, SOD↑, Catalase↑, GPx↑, GSH↑, GPx↑, GR↑, MDA↓, NRF2↑, HO-1↑, COX2/PTGS2↓, PGE2↓, NF-kB↓, IL4↑, IL10↑, IL6↓, TNF-α↓, PPARγ↑, TumCCA↑, FOXO3↓, Casp3↑, IGF-1↓, p27/CDKN1B↑, STAT3↓, CDK2↓, CDK4↓, P21↑, PCNA↓, MMP7↓, MMP9↓,
1714- Lyco,    Lycopene reduces ovarian tumor growth and intraperitoneal metastatic load
- in-vitro, Ovarian, OV-MZ-6 - in-vivo, NA, NA
ChemoSen↑, CA125↓, ITGA5↓, ITGB1↓, MMP9↓, FAK↓, EMT↓, MAPK↓, MMP9↓, antiOx↑, Ki-67↓, MAPK↓,
1715- Lyco,    Pro-oxidant Actions of Carotenoids in Triggering Apoptosis of Cancer Cells: A Review of Emerging Evidence
- Review, Var, NA
antiOx↑, ROS↑, ChemoSen↑, selectivity↑, eff↓, Casp3↑, Casp7↑, Casp9↑, P53↑, BAX↑, DNAdam↑, mtDam↑, Synergy↑,
8418- Lyco,  docx,    A phase I study of docetaxel plus synthetic lycopene in metastatic prostate cancer patients
- Trial, Pca, NA
Dose↝, BioEnh↑, angioG↓, IGF-1↓, ChemoSen↑, BioAv↑, CEC↝,
8414- Lyco,    Exploring the Therapeutic Potential of Lycopene: Mechanisms, Biological Activities, and Health Benefits
- Review, Var, NA - Review, AD, NA
*ROS↓, *Inflam↓, *hepatoP↑, *cardioP↑, *neuroP↑, *AntiArt↑, *Obesity↓, *Wound Healing↑, *BioAv↑, *GSTs↑, *Trx1↑, *SOD↑, *Catalase↑, *ALAT↓, *LDH↓, *AST↓, *MDA↓, *cognitive↑, *memory↑, *NeuroI↓, *Aβ↓, *LRP1↑, *RAGE↓, *NRF2↑, *HO-1↑, tumCV?, Bax:Bcl2↑, DNAdam↑, Apoptosis↑, β-catenin/ZEB1↓, cMyc↓, cycD1/CCND1↓, ROS↓, TumCCA↑, Akt↓, *Synergy↑, *MDA↓, *NF-kB↓, *TGF-β↓, *Casp3↓, *Catalase↑, *GSH↑, *Bcl-2↑, *IL10↑, *MUC1↑, *IBI↑, *RenoP↑, *ChemoSen↑, *Synergy↑, *Synergy↑, *BMD↑,
4781- Lyco,  5-FU,  Chemo,  Cisplatin,    Antioxidant and anti-inflammatory activities of lycopene against 5-fluorouracil-induced cytotoxicity in Caco2 cells
- in-vitro, Colon, Caco-2
chemoP↑, Inflam↓, COX2/PTGS2↓, IL1β↓, IL6↓, TNF-α↓, ROS↑, ChemoSen↑, SOD↓,
4788- Lyco,    Lycopene as a potential anticancer agent: Current evidence on synergism, drug delivery systems and epidemiology (Review)
- Review, Var, NA
AntiCan↑, ChemoSen↑, chemoP↑, Dose↝, BioAv↑, BioAv↑, BioAv↓, cardioP↑, AntiDiabetic↑, hepatoP↑, neuroP↑, MAPK↓, MMP2↓, MMP9↓, TIMP1↑, TIMP2↑,
4791- Lyco,    Investigating into anti-cancer potential of lycopene: Molecular targets
- Review, Var, NA
*antiOx↑, TumCP↓, TumCCA↓, Apoptosis↑, TumCI↓, angioG↓, TumMeta↓, *Risk↓, cycD1/CCND1↓, CycD3↓, cycE/CCNE↓, CDK2↓, CDK4↓, Bcl-2↓, P21↑, p27/CDKN1B↑, P53↑, BAX↑, selectivity↑, MMP↓, Cyt‑c↑, Wnt↓, Synergy↑, PPARγ↑, LDL↓, Akt↓, PI3K↓, mTOR↓, PDGF↓, NF-kB↓, ChemoSen↑,
4798- Lyco,    Enhancing Anticancer Treatment Efficacy With Lycopene: A Comprehensive Review of Clinical and Preclinical Evidence
- Review, Var, NA
AntiCan↑, ChemoSen↑, eff↑, Synergy↑,
4797- Lyco,    A mechanistic updated overview on lycopene as potential anticancer agent
- Review, Var, NA
AntiCan↑, antiOx↓, Apoptosis↑, TumCP↓, TumCCA↑, Risk↓, ROS↓, SOD↑, Catalase↑, GSTs↑, ARE↑, NRF2↑, cycD1/CCND1↓, cycE/CCNE↑, CDK2↑, p27/CDKN1B↑, BAX↑, Bcl-2↓, P53↑, ChemoSen↑,
4792- Lyco,    A Comprehensive Review on the Molecular Mechanism of Lycopene in Cancer Therapy
- Review, Var, NA
*AntiCan↑, *antiOx↑, Inflam↓, Wnt↓, β-catenin/ZEB1↓, *ROS↓, BioAv↑, ROS↓, Risk↓, PGE2↓, COX2/PTGS2↓, p‑ERK↓, P21↑, MMP7↓, MMP9↓, ChemoSen↑, Synergy↑,
8516- MAG,    Magnolol induces cell death through PI3K/Akt-mediated epigenetic modifications boosting treatment of BRAF- and NRAS-mutant melanoma
- in-vitro, Melanoma, NA
TumCCA↑, Apoptosis↑, TumCD↑, PI3K↓, Akt↓, H3K4↓, ChemoSen↑,
8511- MAG,    Suppression of PKCδ/NF-κB Signaling and Apoptosis Induction through Extrinsic/Intrinsic Pathways Are Associated Magnolol-Inhibited Tumor Progression in Colorectal Cancer In Vitro and In Vivo
- vitro+vivo, CRC, HT-29 - in-vitro, Colon, CT26
p‑PKCδ↓, p‑NF-kB↓, TumCI↓, Fas↓, FasL↓, TumCG?, toxicity↓, cl‑Casp8↑, MMP↓, Casp9↑, ChemoSen↑,
4518- MAG,  Cisplatin,    Evaluating the Magnolol Anticancer Potential in MKN-45 Gastric Cancer Cells
- in-vitro, GC, MKN45
ChemoSen↑, tumCV↓, BAX↑, Bcl-2↓, P21↑, P53↑, MMP9↓,
4514- MAG,    Magnolol and its semi-synthetic derivatives: a comprehensive review of anti-cancer mechanisms, pharmacokinetics, and future therapeutic potential
- Review, Var, NA
AntiCan↑, TumCP↓, TumCCA↑, TumMeta↓, angioG↓, NF-kB↓, MAPK↓, PI3K↓, Akt↓, mTOR↓, BioAv↓, *antiOx↑, *Inflam↓, *AntiAg↑, ChemoSen↑, cycD1/CCND1↓, CycB/CCNB1↓, cycE/CCNE↓, CDK2↓, CDK4↓, p27/CDKN1B↑, P21↑, P53↑, PTEN↓, XIAP↓, Mcl-1↓, Casp3↑, Casp9↑, MMP9↑,
4535- MAG,  5-FU,    Magnolol and 5-fluorouracil synergy inhibition of metastasis of cervical cancer cells by targeting PI3K/AKT/mTOR and EMT pathways
- in-vitro, Cerv, NA
ChemoSen↑, TumCP↓, vinculin↓, TumCA↓, TumCMig↓, TumCI↓, p‑Akt↓, p‑PI3K↓, mTOR↓, E-cadherin↑, β-catenin/ZEB1↑, Snail↓, Slug↓,

Showing Research Papers: 551 to 600 of 880
Prev Page 12 of 18 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 880

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↓, 1,   NA↑, 2,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 5,   antiOx↑, 25,   antiOx⇅, 1,   ARE↑, 1,   Bil↝, 1,   Catalase↓, 5,   Catalase↑, 8,   Fenton↑, 11,   frataxin↑, 1,   GCLC↑, 1,   GCLM↑, 1,   GPx↓, 2,   GPx↑, 8,   GPx1↓, 1,   GPx4↓, 18,   GSH↓, 66,   GSH↑, 7,   GSH∅, 1,   GSH/GSSG↓, 5,   GSR↓, 2,   GSR↑, 1,   GSSG↑, 1,   GSTs↓, 2,   GSTs↑, 2,   GSTs↝, 1,   H2O2↓, 1,   H2O2↑, 16,   HO-1↓, 17,   HO-1↑, 18,   HO-2↑, 1,   Iron↓, 1,   Iron↑, 11,   Iron↝, 1,   i-Iron↓, 2,   i-Iron↑, 1,   c-Iron↑, 1,   Keap1↓, 2,   Keap1↑, 2,   lipid-P?, 1,   lipid-P↓, 5,   lipid-P↑, 29,   MDA↓, 4,   MDA↑, 7,   i-MDA↑, 2,   NADH↓, 1,   NADPH/NADP+↓, 1,   NQO1?, 1,   NQO1↓, 3,   NQO1↑, 4,   NRF2↓, 41,   NRF2↑, 36,   NRF2⇅, 1,   NRF2↝, 1,   NRF2∅, 1,   Prx↓, 2,   Prx3↑, 1,   Prx4↑, 1,   Prx6↑, 1,   PrxI↓, 1,   PYCR1↓, 1,   RNS↑, 2,   ROS?, 1,   ROS↓, 36,   ROS↑, 376,   ROS⇅, 11,   ROS↝, 5,   i-ROS↓, 1,   i-ROS↑, 4,   mt-ROS↓, 1,   mt-ROS↑, 8,   RPM↑, 1,   SOD↓, 10,   SOD↑, 11,   SOD1↓, 2,   SOD1↑, 2,   SOD2↓, 2,   SOD2↑, 2,   TBARS↑, 1,   Thiols↓, 2,   Trx↓, 5,   Trx1↑, 1,   ox-Trx1↑, 1,   TrxR↓, 15,   TrxR1↓, 4,   TrxR1⇅, 1,   uricA↓, 1,   VitC↓, 1,   VitE↓, 1,   xCT/SLC7A11↓, 7,  

Metal & Cofactor Biology(tgid=2) ⓘ

Ferritin↓, 5,   FTH1↓, 1,   FTL↑, 1,   IronCh↑, 3,   IronCh∅, 1,   NCOA4↑, 2,   STEAP3↑, 1,   Tf↓, 1,   Tf↑, 1,   TfR1/CD71↓, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

ADP:ATP↓, 1,   BCR-ABL↓, 1,   CDC2↓, 5,   CDC25↓, 7,   CDC25↑, 1,   compI↓, 4,   compII↓, 1,   compIII↓, 1,   compV↓, 1,   EGF↓, 4,   ETC↓, 4,   ETC↑, 1,   ETC↝, 1,   HSP60/HSPD1↓, 3,   HSP60/HSPD1↑, 1,   Insulin↓, 5,   mitResp↓, 6,   mitResp↑, 1,   Mortalin↓, 1,   mtDam↓, 1,   mtDam↑, 33,   OCR↓, 8,   OCR↑, 2,   OXPHOS↓, 6,   OXPHOS↑, 6,   OXPHOS↝, 1,   mt-OXPHOS↓, 3,   PDH↓, 3,   PDH↝, 1,   PGC-1α↑, 1,   SDH↓, 1,   SDH↑, 1,   SIRT3↓, 2,   SIRT3↑, 3,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12LOX?, 1,   12LOX↓, 2,   5LO↓, 4,   ACC↑, 2,   p‑ACC↑, 1,   ACC-α↓, 1,   ACLY↓, 6,   ACSL4↑, 3,   ACSL5↑, 2,   adiP↑, 1,   ADO↓, 1,   ALAT↓, 2,   ALAT↑, 1,   AminoA↓, 1,   AMP↑, 1,   AMPK↓, 1,   AMPK↑, 35,   p‑AMPK↑, 1,   p‑AMT/GCST/T-protein↑, 1,   ATP↓, 37,   ATP↑, 2,   i-ATP↓, 1,   ATP:AMP↓, 1,   CAIX/CA9↓, 2,   CAIX/CA9↑, 1,   citrate↓, 1,   CPT1A↓, 1,   CRM↑, 1,   ECAR↓, 2,   ECAR∅, 1,   ENO1↓, 1,   FABP5/E-FABP↓, 1,   FASN↓, 6,   FASN↑, 2,   FBPase↑, 2,   G6PD↓, 1,   GAPDH↓, 5,   GLS↓, 1,   glucoNG↓, 2,   glucoNG↑, 2,   glucose↓, 2,   glucose↝, 1,   GlucoseCon↓, 21,   GlucoseCon↑, 1,   GlucoseCon∅, 1,   GlutaM↓, 1,   GlutMet↓, 1,   glyC↓, 1,   Glycolysis↓, 60,   Glycolysis↝, 1,   Glycolysis∅, 1,   GSK‐3β↓, 15,   GSK‐3β↑, 6,   p‑GSK‐3β↓, 8,   H2S↑, 1,   Histones↑, 1,   HK1↓, 2,   HK2↓, 31,   HK2∅, 1,   HMG-CoA↓, 4,   KeyT↑, 1,   lactateProd↓, 18,   lactateProd↑, 4,   lactateProd∅, 1,   LDHA↓, 11,   LDHA∅, 1,   LDL↓, 4,   LDL↑, 1,   lipoGen↓, 2,   MATs↓, 1,   MCT4↓, 2,   MethCyc↓, 1,   NAD↓, 2,   NAD↑, 1,   NADH:NAD↓, 1,   NADPH↓, 5,   NADPH↑, 2,   PDK1 / PDPK1↓, 8,   PDKs↓, 1,   PFK↓, 6,   PFK1↓, 8,   PFK2?, 1,   PFK2↓, 2,   PFKP↓, 2,   PKM2↓, 25,   PKM2↑, 1,   polyA↓, 1,   Pyrim↓, 1,   Pyruv↓, 3,   SAT1↑, 1,   SCD1↓, 2,   SIRT1↓, 9,   SIRT1↑, 8,   SIRT2↓, 1,   SREBP1/SREBF1↓, 1,   SREBP2↓, 3,   TCA?, 1,   TCA↓, 6,   TCA↑, 2,   TS↓, 5,   Warburg↓, 12,   β-oxidation↓, 2,  

Cell Death(tgid=5) ⓘ

AIF↑, 15,   APAF1↑, 9,   Apoptosis?, 3,   Apoptosis↓, 9,   Apoptosis↑, 323,   Apoptosis∅, 1,   m-Apoptosis↑, 1,   mt-Apoptosis↑, 5,   ASC↓, 1,   BAD↓, 2,   BAD↑, 7,   p‑BAD↓, 1,   Bak↑, 6,   BAX↓, 5,   BAX↑, 122,   BAX⇅, 1,   Bax:Bcl2↑, 31,   Bcl-2↓, 131,   Bcl-2↑, 3,   Bcl-xL↓, 36,   Bcl-xL↑, 2,   BID↓, 3,   BID↑, 3,   p‑BID↓, 1,   BIM↑, 7,   BNIP3↑, 2,   Casp↓, 2,   Casp↑, 52,   Casp↝, 1,   cl‑Casp↑, 1,   Casp1↓, 1,   Casp1↑, 1,   Casp12↑, 1,   Casp2↑, 4,   Casp3↓, 6,   Casp3↑, 162,   cl‑Casp3↑, 26,   proCasp3↑, 1,   pro‑Casp3↑, 1,   CASP4↑, 1,   Casp6↑, 1,   Casp7↓, 1,   Casp7↑, 20,   cl‑Casp7↑, 3,   Casp8↑, 32,   Casp8∅, 1,   cl‑Casp8↑, 8,   Casp9↓, 2,   Casp9↑, 101,   cl‑Casp9↑, 11,   proCasp9↓, 1,   cFLIP↓, 3,   Cupro↑, 2,   Cyt‑c↓, 3,   Cyt‑c↑, 93,   mt-Cyt‑c↓, 1,   Diablo↑, 7,   DR5↑, 27,   Endon↑, 1,   FADD↑, 4,   Fap1↓, 1,   Fas↓, 3,   Fas↑, 16,   FasL↓, 2,   FasL↑, 6,   Ferroptosis↑, 39,   GSDME↑, 1,   IAP1↓, 11,   IAP2/BIRC3↓, 6,   IAP2/BIRC3↑, 1,   cl‑IAP2/BIRC3↑, 1,   ICAD↓, 1,   ICD↑, 1,   iNOS↓, 13,   iNOS↑, 1,   Mcl-1↓, 31,   Mcl-1↑, 1,   p‑Mcl-1↓, 1,   MDM2↓, 10,   MDM2↑, 1,   p‑MDM2↓, 2,   MOMP↓, 1,   MOMP↑, 4,   Necroptosis↑, 3,   necrosis↑, 5,   NOXA↑, 1,   p38↓, 5,   p38↑, 18,   p‑p38↓, 1,   p‑p38↑, 5,   Paraptosis↑, 3,   pS2/TFF1↓, 1,   PUMA↑, 7,   Pyro↑, 5,   survivin↓, 64,   TRAIL↑, 7,   TRAIL⇅, 1,   TRAILR↑, 1,   TumCD↓, 2,   TumCD↑, 32,   TUNEL↑, 1,   XIAP↓, 30,   XIAP↑, 1,   YAP/TEAD↓, 7,   YAP/TEAD↝, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 178,   Akt↑, 7,   p‑Akt↓, 43,   AKT1↓, 2,   AMPKα↑, 1,   BRAF↓, 1,   CaMKII ↓, 2,   p‑CaMKII ↓, 1,   CIP2A↓, 1,   CK2↓, 5,   cMET↓, 4,   CREB↓, 1,   cSrc↓, 4,   DDIT4↑, 1,   DYRK1B↓, 1,   EF-1α↓, 1,   EGFR↓, 36,   EGFR↑, 1,   p‑EGFR↓, 3,   ERK↓, 49,   ERK↑, 8,   ERK↝, 1,   p‑ERK↓, 20,   p‑ERK↑, 1,   e-ERK↑, 1,   FGFR1↓, 1,   FOXD3↑, 3,   HCAR2↑, 1,   HER2/EBBR2↓, 15,   p‑HER2/EBBR2↓, 1,   HGF/c-Met↓, 3,   Hippo↑, 1,   IGF-1R↓, 9,   p‑IGF-1R↓, 1,   IGFR↓, 2,   IKKα↓, 6,   p‑IKKα↓, 1,   IκB↓, 4,   p‑IκB↓, 1,   JAK↓, 7,   JAK↝, 1,   JAK1↓, 8,   JAK2↓, 22,   JNK↓, 8,   JNK↑, 24,   p‑JNK↓, 2,   p‑JNK↑, 4,   p‑MAP2K1/MEK1↓, 1,   MAPK↓, 50,   MAPK↑, 19,   p‑MAPK↓, 1,   p‑MAPK↑, 1,   MEK↓, 5,   MEK↑, 1,   p‑MEK↓, 1,   MKP1↓, 1,   MKP2↓, 1,   mTOR↓, 104,   mTOR↑, 3,   p‑mTOR↓, 6,   mTORC2↓, 3,   mTORC2↑, 1,   p42↓, 1,   p70S6↓, 2,   P70S6K↓, 4,   P70S6K↑, 1,   p‑P70S6K↓, 2,   P90RSK↓, 1,   p‑PDGFR-BB↓, 1,   PDGFRB↓, 1,   PI3K↓, 133,   PI3K↑, 4,   p‑PI3K↓, 6,   PI3K/Akt↓, 4,   PI3K/mTOR/ETS2↓, 1,   PIAS-3↑, 1,   PIK3CA↓, 1,   PKA↓, 2,   PKCδ↓, 9,   p‑PKCδ↓, 1,   PP2A↑, 1,   PTEN↓, 3,   PTEN↑, 37,   p‑PTEN↓, 1,   Raf↓, 4,   c-Raf↓, 1,   RAS↓, 12,   RTK-RAS↓, 1,   p‑S6K↓, 1,   SHP1↑, 3,   Sp1/3/4↓, 15,   Src↓, 2,   p‑Src↓, 1,   STAT↓, 3,   STAT3↓, 86,   STAT3↑, 2,   STAT3↝, 2,   p‑STAT3↓, 10,   p‑STAT3↑, 3,   mt-STAT3↓, 1,   STAT5↓, 4,   STAT6↓, 2,   p‑STAT6↓, 1,   TK1↓, 2,   TSC2↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

AFAP1-AS1↓, 1,   ATF2↓, 1,   ATF3↓, 1,   ATF4↓, 1,   ATF4↑, 8,   ATF4↝, 1,   CBP↓, 1,   cJun↓, 7,   cJun↑, 2,   cMyc↓, 41,   cMyc↑, 2,   p‑cMyc↑, 1,   DNMT1↓, 9,   DNMT3A↓, 2,   DNMT3B↓, 2,   DNMTs↓, 7,   EZH2↓, 3,   FOXM1↓, 3,   FOXO↑, 2,   FOXO1↓, 3,   FOXO1↑, 2,   FOXO3↓, 6,   FOXO3↑, 6,   p‑FOXO3↓, 2,   FOXO4↓, 1,   FOXO4↑, 2,   GATA3↑, 1,   H3↓, 2,   H3↑, 1,   p‑H3↓, 1,   ac‑H3↑, 2,   H3K4↓, 1,   H4↓, 1,   H4↑, 2,   ac‑H4↑, 1,   HATs↓, 4,   HATs↑, 1,   HDAC↓, 30,   HDAC1↓, 4,   HDAC2↓, 3,   HDAC3↓, 2,   HDAC8↓, 3,   HES1↓, 2,   miR-106b↓, 1,   miR-107↑, 1,   miR-124-3p↓, 1,   miR-130a↓, 1,   miR-133a-3p↑, 1,   miR-139-5p↑, 1,   miR-143↑, 1,   miR-155↓, 2,   miR-192-5p↑, 1,   miR-195↑, 1,   miR-199↓, 1,   miR-19b↓, 1,   miR-200b↑, 1,   miR-21↓, 7,   miR-218↑, 1,   miR-224↓, 1,   miR-25-5p↓, 1,   miR-27a-3p↓, 3,   miR-30a-5p↑, 1,   miR-340↓, 1,   miR-34a↓, 1,   miR-34a↑, 8,   miR-384↑, 1,   miR-422a↑, 1,   miR-429↑, 1,   miR-490↑, 1,   miR-545↑, 1,   miR-99↑, 1,   Myc↓, 6,   MYCN↓, 1,   n-MYC↓, 2,   NDRG1↑, 1,   OCT4↓, 14,   other?, 1,   other↓, 7,   other↑, 11,   other↝, 26,   PAX2↓, 1,   PhotoS↑, 3,   SALL4↓, 1,   sonoS↑, 2,   SOX2↓, 9,   SOX4↓, 3,   SOX4↑, 1,   SOX9?, 1,   SOX9↓, 1,   TCF-4↓, 1,   TFE3↑, 1,   TLE1↓, 1,   tumCV?, 1,   tumCV↓, 78,   tumCV↑, 2,   tumCV∅, 1,   YMcells↓, 1,   ZBTB10↑, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

ATF6↑, 3,   CHOP/DDIT3↓, 1,   CHOP/DDIT3↑, 22,   cl‑CHOP/DDIT3↑, 1,   eIF2α↓, 1,   eIF2α↑, 3,   p‑eIF2α↑, 5,   ER Stress↓, 1,   ER Stress↑, 62,   GRP78/BiP?, 1,   GRP78/BiP↓, 2,   GRP78/BiP↑, 10,   HSP27↓, 4,   HSP27↝, 1,   HSP70/HSPA5↓, 6,   HSP70/HSPA5↑, 4,   HSP70/HSPA5↝, 1,   HSP72↑, 1,   HSP90↓, 13,   HSPs↓, 1,   HSPs↑, 1,   HTRA↓, 1,   IRE1↑, 4,   PERK↑, 8,   Proteasome?, 1,   Proteasome↓, 1,   UPR↑, 9,   XBP-1↑, 3,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG3↑, 1,   ATG5↑, 7,   ATG7↑, 3,   Beclin-1/ATG6↓, 2,   Beclin-1/ATG6↑, 17,   Beclin-1/ATG6⇅, 1,   CTSK↓, 1,   LAMP2↑, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 3,   LC3A↑, 1,   LC3B↑, 1,   LC3B-II↑, 4,   LC3I↑, 1,   LC3II↓, 1,   LC3II↑, 17,   LC3s↓, 2,   lysoMP↑, 1,   MitoP↓, 1,   p62↓, 8,   p62↑, 6,   p‑p62↑, 1,   SESN2↑, 3,   TumAuto↓, 3,   TumAuto↑, 65,   TumAuto↝, 2,   mt-TumAuto↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

APE1/APEX1↓, 1,   ATM↑, 3,   ATR↑, 1,   BRCA1↓, 4,   BRCA1↑, 1,   p‑BRCA1↑, 1,   BRCA2↓, 2,   BRCA2↑, 1,   DFF45↑, 1,   DNAdam↓, 3,   DNAdam↑, 99,   DNArepair↓, 4,   DNArepair↑, 3,   ERCC1↓, 1,   ERCC3↑, 1,   m-FAM72A↓, 1,   FEN1↓, 1,   HR↓, 1,   hTERT/TERT↓, 13,   Ku70/XRCC6↓, 1,   MGMT↓, 2,   p16↑, 3,   P53?, 1,   P53↓, 6,   P53↑, 106,   P53↝, 1,   P53∅, 1,   p‑P53↑, 5,   PARP↓, 2,   PARP↑, 21,   PARP↝, 1,   cl‑PARP↓, 2,   cl‑PARP↑, 76,   PARP1↓, 1,   PARP1↑, 3,   PCNA↓, 29,   RAD51↓, 2,   SIRT6↓, 3,   SIRT6↑, 1,   Telomerase↓, 14,   TOP1↓, 10,   TOP2↓, 6,   TOP2↑, 3,   TP53↓, 1,   TP53↑, 3,   TRF2↓, 1,   UHRF1↓, 1,   XRCC1↓, 2,   γH2AX↓, 1,   γH2AX↑, 10,   γH2AX↝, 1,   p‑γH2AX↑, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

ANAPC2↑, 1,   AURKB↑, 1,   CC(CDKs/cyclins)↓, 2,   CDK1?, 1,   CDK1↓, 13,   CDK1↑, 4,   p‑CDK1↓, 2,   CDK2↓, 37,   CDK2↑, 4,   p‑CDK2↓, 1,   CDK4↓, 50,   CDK4↑, 3,   p‑CDK4↓, 1,   CDK4/6↓, 1,   CDK6↓, 20,   CDK6↑, 4,   CDK7↓, 1,   CDKN1C/p57↑, 1,   CHK1↓, 2,   p‑CHK1↓, 1,   p‑CHK1↑, 1,   Chk2↓, 1,   Chk2↑, 1,   p‑Chk2↑, 1,   Cyc↓, 3,   cycA1/CCNA1↓, 10,   cycA1/CCNA1↑, 1,   CycB/CCNB1↓, 25,   CycB/CCNB1↑, 3,   cycD1/CCND1↓, 94,   cycD1/CCND1↑, 3,   p‑cycD1/CCND1↓, 1,   CycD3↓, 3,   cycE/CCNE↓, 21,   cycE/CCNE↑, 1,   cycE1↓, 1,   cycF↑, 1,   E2Fs↓, 5,   GADD45A↓, 1,   GADD45A↑, 2,   Ki-67↓, 34,   MAD↓, 1,   mitA↑, 5,   p19↑, 1,   P21?, 2,   P21↓, 4,   P21↑, 81,   p27/CDKN1B↓, 3,   p27/CDKN1B↑, 31,   PLK1↓, 1,   pRB↓, 2,   p‑pRB↓, 3,   RB1↓, 1,   RB1↑, 2,   p‑RB1↓, 6,   Securin↓, 2,   TubPol↓, 1,   TumCCA?, 2,   TumCCA↓, 12,   TumCCA↑, 252,   TumCCA⇅, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

ALDH↓, 11,   ALDH1A1↓, 5,   Axin2↑, 1,   CD133↓, 13,   CD24↓, 2,   CD34↓, 2,   cFos↓, 10,   cFos↑, 1,   cMYB↓, 1,   CSCs?, 1,   CSCs↓, 70,   CSCs↑, 2,   CSCsMark↓, 1,   Diff↓, 1,   Diff↑, 9,   EIF4E↓, 3,   EP4/PTGER4↑, 1,   FGF↓, 2,   Gli↓, 1,   Gli1↓, 11,   HH↓, 15,   HH↝, 1,   HMGCR↓, 2,   HMGCR⇅, 1,   IGF-1↓, 16,   IGF-2↓, 1,   IGFBP1↑, 1,   IGFBP3↑, 1,   JAG1↓, 1,   Jun↓, 1,   Ki-67↓, 34,   Let-7↑, 2,   LRP6↓, 2,   mTORC1↓, 11,   p‑mTORC1↓, 1,   Nanog↓, 14,   Nestin↓, 3,   NICD↓, 1,   NOTCH↓, 19,   NOTCH↑, 1,   NOTCH1↓, 14,   NOTCH1↑, 1,   NOTCH3↓, 3,   OGF↑, 1,   OGFr↑, 3,   p300↓, 1,   PTCH1↓, 4,   PTCH2↓, 1,   SAL↑, 1,   SCF↓, 2,   Shh↓, 9,   Smo↓, 6,   Smo∅, 1,   STAT1↓, 1,   TAZ↓, 1,   TumCG?, 1,   TumCG↓, 149,   TumCG↑, 4,   TumCG∅, 2,   TumCP?, 1,   TumCP↓, 214,   TumCP↑, 5,   Wnt↓, 55,   Wnt/(β-catenin)↓, 5,   ZFX↓, 1,  

Migration(tgid=13) ⓘ

AEG1↓, 1,   annexin II↓, 1,   AntiAg?, 1,   AntiAg↓, 1,   AntiAg↑, 1,   AP-1↓, 9,   ASAP2↓, 1,   ATPase↑, 1,   AXL↓, 1,   BACH1↓, 1,   BACH1↑, 1,   Ca+2↓, 3,   Ca+2↑, 38,   Ca+2↝, 1,   i-Ca+2?, 1,   i-Ca+2↓, 1,   i-Ca+2↑, 1,   cal2↓, 1,   cal2↑, 2,   CCN2/CTGF↓, 2,   Cdc42↓, 2,   Chl↑, 1,   i-Chl↑, 1,   Cofilin↓, 1,   COL4A3↓, 1,   DLC1↑, 1,   E-cadherin↓, 6,   E-cadherin↑, 46,   EMT?, 1,   EMT↓, 95,   EMT↑, 1,   EMT↝, 1,   EpCAM↓, 3,   F-actin↓, 1,   FAK↓, 21,   p‑FAK↓, 2,   p‑FAK↑, 1,   fascin↓, 1,   Fibronectin↓, 4,   Furin↓, 1,   GLI2↓, 2,   ITGA2↓, 1,   ITGA5↓, 3,   ITGA6↓, 1,   ITGB1↓, 7,   ITGB3↓, 3,   ITGB4↓, 2,   ITGB6↓, 1,   KRAS↓, 4,   LAMs↓, 2,   LEF1↓, 1,   MALAT1↓, 4,   MET↓, 2,   p‑MET↓, 1,   MMP1↓, 7,   MMP13↓, 2,   MMP16↓, 1,   MMP2↓, 88,   MMP2⇅, 1,   MMP3↓, 6,   MMP7↓, 8,   MMP9↓, 112,   MMP9↑, 1,   MMP9⇅, 1,   MMPs↓, 36,   MUC4↓, 3,   N-cadherin↓, 30,   Na+↝, 1,   NEDD9↓, 1,   PAK1↓, 5,   pax↓, 1,   PDGF↓, 4,   Rac1↓, 3,   Rho↓, 5,   ROCK1↓, 6,   Sharpin↓, 1,   Slug↓, 9,   Smad1↓, 1,   Smad1↑, 2,   SMAD2↓, 1,   SMAD3↓, 2,   SMAD3↑, 1,   SMAD4↓, 1,   SMAD4↑, 1,   Snail↓, 26,   STAC2↓, 1,   TET1↑, 1,   TGF-β↓, 20,   TGF-β↑, 4,   TIMP1↓, 3,   TIMP1↑, 14,   TIMP2↓, 2,   TIMP2↑, 9,   TIMP3↑, 1,   TRIB3↑, 3,   TSP-1↑, 2,   TumCA↓, 2,   TumCA↑, 1,   TumCI↓, 105,   TumCMig↓, 97,   TumCMig↑, 1,   TumMeta?, 1,   TumMeta↓, 107,   TumMeta↑, 9,   TumPF↓, 1,   Twist↓, 13,   Tyro3↓, 1,   uPA↓, 13,   uPAR↓, 1,   Vim↓, 34,   Vim↑, 1,   vinculin↓, 1,   Zeb1↓, 13,   ZEB2↓, 3,   α-SMA↓, 1,   α-tubulin↓, 2,   β-catenin/ZEB1↓, 70,   β-catenin/ZEB1↑, 3,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 147,   angioG↑, 4,   CCN1/CYR61↓, 1,   CD31/PECAM-1↓, 4,   ECM/TCF↓, 1,   eNOS↓, 3,   eNOS↑, 1,   HIF-1↓, 5,   Hif1a↓, 77,   Hif1a↑, 2,   Hypoxia↓, 2,   LOX1↓, 1,   LymphAG↓, 1,   NO↓, 5,   NO↑, 3,   NO↝, 1,   PHDs↓, 1,   TYMP/ECGF1↓, 1,   VCAM-1↓, 4,   VEGF↓, 123,   VEGF↑, 1,   VEGFR1↓, 1,   VEGFR2/KDR/Flk1↓, 16,  

Barriers & Transport(tgid=15) ⓘ

ABCG1↓, 1,   BBB↓, 1,   BBB↑, 12,   CellMemb↑, 2,   CLDN1↓, 3,   CLDN2↓, 2,   CLDN2↑, 1,   CTR1↑, 2,   EPR↑, 21,   GLUT1↓, 16,   GLUT1↑, 1,   GLUT2↓, 3,   GLUT3↑, 1,   GLUT4↓, 1,   MMP?, 1,   MMP↓, 138,   MMP↑, 2,   MMP↝, 1,   MPT↑, 6,   Na+↝, 1,   OATPs↓, 2,   TRPC1↑, 1,   TRPM7↓, 1,   TRPV1↓, 1,   TRPV1↑, 3,   TRPV1↝, 1,   TRPV2↑, 2,   ZO-1↑, 2,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CB2 / CNR2↑, 1,   CCR7↓, 2,   CD4+↓, 1,   CD4+↑, 1,   CD44↓, 17,   CD47↓, 1,   CD8+↑, 6,   p‑cDC2↓, 1,   COX1↓, 2,   COX2/PTGS2↓, 96,   COX2/PTGS2↑, 1,   CR3↝, 1,   CXCL1↓, 1,   CXCL12↓, 2,   CXCL16↓, 1,   CXCL6/GCP-2↓, 1,   CXCR4↓, 11,   DR4↑, 8,   DR6↑, 1,   FOXP3↓, 2,   FOXP3↑, 1,   Gal-3↓, 3,   HCAR1↓, 1,   HCAR2↑, 1,   HLA↑, 1,   HMGB1↓, 6,   ICAM-1↓, 6,   IFN-γ↓, 3,   IFN-γ↑, 2,   Igs↑, 2,   IL1↓, 5,   IL1↑, 2,   IL10↓, 5,   IL10↑, 4,   IL12↓, 2,   IL12↑, 2,   IL1α↓, 1,   IL1β↓, 19,   IL1β↑, 1,   IL2↓, 4,   IL2↑, 6,   IL4↓, 4,   IL4↑, 2,   IL6↓, 43,   IL8↓, 11,   IL8↑, 1,   Imm↑, 36,   Imm↝, 6,   INF-γ↑, 1,   Inflam↓, 55,   Inflam↑, 1,   Inflam↝, 1,   LPS↓, 1,   LRIG1↑, 1,   M2 MC↓, 4,   MCP1/CCL2↓, 5,   MCT1↓, 2,   MIP2↓, 1,   MyD88↑, 1,   NAF1↓, 2,   NF-kB↓, 191,   NF-kB↑, 8,   NF-kB↝, 1,   p‑NF-kB↓, 3,   p‑NF-kB↑, 2,   NK cell↑, 14,   NLRP3↓, 4,   NLRP3↑, 1,   p50↓, 2,   p65↓, 9,   p‑p65↓, 3,   PAF↓, 1,   PD-1↓, 4,   PD-L1↓, 7,   PGE2↓, 26,   PSA↓, 9,   PSA∅, 1,   RAGE↓, 1,   T-Cell↑, 4,   T-Cell↝, 1,   TCF↓, 1,   TCF↑, 1,   TCF7/TCF1↓, 1,   Th1 response↑, 2,   Th2↑, 1,   TLR4↓, 4,   TLR4↑, 1,   TNF-α↓, 38,   TNF-α↑, 6,   TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, 2,   TRAF1↓, 1,   Treg lymp↓, 3,  

Cellular Microenvironment(tgid=17) ⓘ

pH↓, 2,   pH↑, 3,   pH↝, 2,   e-pH↓, 1,   e-pH↑, 3,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↓, 2,   PTN↓, 1,   SYN1↑, 1,  

Protein Aggregation(tgid=19) ⓘ

PSEN1/PS1↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AhR↑, 1,   AR↓, 14,   ER-α36↓, 4,   ER(estro)↓, 1,   Estro↝, 1,   GR↑, 1,   PPARα↓, 1,   PPARγ↓, 2,   PPARγ↑, 7,   PRL↓, 1,   PXR, NR1I2↓, 1,   RANKL↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ABCC2↓, 1,   ABCG2↓, 3,   BioAv↓, 69,   BioAv↑, 80,   BioAv↝, 20,   BioEnh?, 1,   BioEnh↑, 6,   CBR1↓, 1,   chemoR↓, 2,   ChemoSen?, 5,   ChemoSen↓, 17,   ChemoSen↑, 871,   ChemoSen⇅, 3,   ChemoSen↝, 2,   ChemoSen∅, 7,   CompStab?, 1,   CompStab↓, 4,   CompStab↑, 4,   CompStab↝, 2,   CYP1A1↓, 4,   CYP1A1↑, 3,   CYP1A2↑, 1,   CYP1B1↓, 1,   CYP1B1↑, 2,   CYP2A3/CYP2A6↓, 1,   CYP2E1↑, 1,   CYP3A4↓, 5,   DDS↑, 2,   Dose?, 8,   Dose↓, 5,   Dose↑, 17,   Dose⇅, 1,   Dose↝, 98,   Dose∅, 18,   eff↓, 77,   eff↑, 182,   eff⇅, 1,   eff↝, 21,   eff∅, 3,   GSTA1↓, 1,   GSTA1↑, 2,   GSTM1↑, 1,   GSTP1/GSTπ↓, 2,   GSTZ1↝, 1,   Half-Life↓, 18,   Half-Life↑, 4,   Half-Life↝, 17,   Half-Life∅, 3,   MDR1↓, 20,   MRP↓, 1,   MRP1/ABCC1↓, 9,   MRP1/ABCC1↝, 1,   NAT↓, 1,   P-gp/ABCB1↓, 42,   P-gp/ABCB1↑, 1,   P-gp/ABCB1↝, 1,   P450↓, 5,   P450↝, 1,   RadioS?, 1,   RadioS↓, 3,   RadioS↑, 150,   RadioS↝, 1,   selectivity?, 2,   selectivity↑, 154,   Synergy↑, 197,   Synergy↝, 1,   TET2↑, 3,  

Clinical Biomarkers(tgid=22) ⓘ

AFP?, 1,   AFP↓, 1,   AFP↑, 1,   ALAT↓, 2,   ALAT↑, 1,   ALP↓, 2,   AR↓, 14,   ascitic↓, 1,   AST↓, 2,   AST↑, 1,   BG↓, 4,   Bil↝, 1,   BloodF↑, 1,   BMD↑, 2,   BRAF↓, 1,   BRCA1↓, 4,   BRCA1↑, 1,   p‑BRCA1↑, 1,   CA125↓, 1,   CEA↓, 2,   CEC↝, 1,   creat↓, 1,   E6↓, 1,   E7↓, 1,   EGFR↓, 36,   EGFR↑, 1,   p‑EGFR↓, 3,   EZH2↓, 3,   Ferritin↓, 5,   FOXM1↓, 3,   HER2/EBBR2↓, 15,   p‑HER2/EBBR2↓, 1,   hTERT/TERT↓, 13,   IL6↓, 43,   KeyT↑, 1,   KRAS↓, 4,   LDH↓, 8,   LDH↑, 1,   LDH↝, 1,   Myc↓, 6,   NOS2↑, 1,   NSE↓, 1,   PD-L1↓, 7,   PSA↓, 9,   PSA∅, 1,   RAGE↓, 1,   RBC↑, 1,   TG/TAG↓, 1,   TP53↓, 1,   TP53↑, 3,   TRIB3↑, 3,  

Functional Outcomes(tgid=23) ⓘ

AntiAge↑, 2,   AntiCan↓, 3,   AntiCan↑, 93,   AntiCan?, 1,   AntiCan∅, 1,   antiCG↓, 1,   antiD↑, 1,   AntiDiabetic↑, 1,   antiNeop↑, 5,   antiNeop∅, 1,   AntiTum↓, 1,   AntiTum↑, 42,   Appetite↑, 1,   cachexia↓, 5,   cardioP↑, 19,   CardioT↓, 3,   chemoP?, 1,   chemoP↑, 91,   chemoPv↑, 27,   ChemoSideEff↓, 19,   ChemoSideEff∅, 1,   cognitive↑, 2,   fatigue↓, 2,   fatigue∅, 1,   FTO↓, 1,   FTO↑, 1,   hepatoP↑, 16,   hepatoP↝, 1,   hepatoP∅, 1,   kidSt↓, 1,   memory↑, 1,   Mucositis↓, 1,   neuroP↑, 12,   NP/CIPN↓, 3,   NP/CIPN↑, 1,   NP/CIPN↝, 1,   ORR↑, 1,   OS↓, 1,   OS↑, 50,   OS∅, 1,   Pain↓, 5,   PFS↓, 1,   PFS↑, 2,   PFS∅, 1,   QoL↑, 28,   QoL∅, 2,   radioP↑, 22,   Remission↑, 6,   RenoP↑, 9,   RenoP∅, 1,   Risk↓, 41,   Risk↑, 2,   Risk∅, 1,   Sleep↑, 2,   toxicity↓, 35,   toxicity↑, 8,   toxicity⇅, 1,   toxicity↝, 24,   toxicity∅, 8,   TumVol↓, 37,   TumVol⇅, 1,   TumW↓, 20,   TumW⇅, 1,   Weight↓, 1,   Weight↑, 4,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↓, 1,   AntiP↑, 1,   AntiViral↑, 1,   Bacteria↓, 2,   GutMicro↑, 11,   GutMicro↝, 1,   Sepsis↓, 2,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr?, 2,   Ingr↝, 4,  
Total Targets: 1251

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx?, 1,   antiOx↓, 9,   antiOx↑, 105,   ARE↑, 1,   Catalase↑, 42,   Copper↓, 1,   Fenton↓, 3,   GPx↑, 35,   GPx1↑, 3,   GPx4↑, 3,   GSH↓, 1,   GSH↑, 45,   GSR↑, 7,   GSSG↓, 1,   GSSG∅, 1,   GSTs↑, 16,   H2O2↓, 3,   H2O2↑, 1,   HDL↓, 1,   HDL↑, 3,   HO-1?, 1,   HO-1↓, 2,   HO-1↑, 27,   Iron↓, 2,   Iron↑, 1,   Iron∅, 1,   i-Iron↓, 1,   Keap1↓, 2,   Keap1↝, 1,   lipid-P?, 1,   lipid-P↓, 36,   MDA↓, 28,   MDA↑, 1,   MPO↓, 5,   NADH↓, 1,   NOX↓, 1,   NOX4↓, 1,   NQO1↑, 2,   Nrf1↑, 1,   NRF2?, 1,   NRF2↓, 1,   NRF2↑, 51,   Prx↑, 1,   RNS↓, 5,   ROS?, 4,   ROS↓, 121,   ROS↑, 2,   ROS↝, 1,   ROS∅, 2,   i-ROS↑, 1,   mt-ROS?, 1,   selenoP↑, 3,   SOD↓, 1,   SOD↑, 51,   SOD1↑, 5,   SOD2↑, 3,   TAC↑, 6,   TBARS↓, 2,   Trx↑, 1,   Trx1↑, 1,   VitC↑, 1,   VitE↓, 1,   VitE↑, 1,   xCT/SLC7A11↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

Ferritin↓, 1,   FPN↑, 1,   IronCh↑, 3,   TfR1/CD71↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

compI↑, 1,   compII↑, 1,   compIII↑, 1,   DRP1/DNM1L↓, 1,   EGF↓, 1,   Insulin↓, 2,   Insulin↑, 2,   MFN2↑, 1,   mitResp↑, 2,   mtDam↓, 1,   OCR↑, 1,   PGC-1α↑, 1,   PGC-1α↝, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

15-LOX/ALOX15↓, 1,   5LO↓, 5,   adiP↑, 1,   ALAT↓, 14,   AMPK↓, 1,   AMPK↑, 7,   ATP↓, 1,   ATP↑, 4,   CRM↑, 1,   cytoP450↓, 1,   FABP4↓, 1,   glucose↓, 9,   GlucoseCon↑, 2,   glyC↓, 1,   GSK‐3β↓, 2,   GSK‐3β↑, 1,   LDL↓, 8,   lipidLev↓, 3,   NAD↓, 1,   NAD↑, 1,   NADPH↓, 2,   NADPH↑, 2,   NH3↓, 1,   SIRT1↑, 4,   SREBF2⇅, 1,  

Cell Death(tgid=5) ⓘ

AIF↓, 1,   Apoptosis↓, 9,   BAX↓, 3,   Bcl-2↓, 1,   Bcl-2↑, 4,   Bcl-xL↑, 1,   Casp↓, 1,   Casp12↓, 1,   Casp3↓, 12,   Casp3∅, 1,   Casp9↓, 5,   Cyt‑c↓, 1,   Cyt‑c∅, 1,   Fas↓, 1,   FasL↓, 1,   Ferroptosis↓, 3,   GranB/GZMB↓, 1,   iNOS↓, 7,   p38↓, 4,   p38↑, 1,   p‑p38↓, 1,   TUNEL↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 3,   Akt↑, 8,   Akt↝, 1,   p‑Akt↓, 1,   p‑Akt↑, 1,   Akt2↓, 1,   AMPKα↑, 1,   CREB↑, 1,   ERK↓, 1,   ERK↑, 2,   IGF-1R↓, 1,   IKKα↓, 1,   JAK↓, 1,   JAK2↑, 2,   JNK↓, 3,   p‑JNK↓, 4,   MAPK↓, 8,   MAPK↑, 1,   MAPK↝, 1,   mTOR↓, 3,   mTOR↑, 2,   p‑mTOR↓, 1,   PDGFR-BB↓, 1,   PI3K↓, 2,   PI3K↑, 4,   PKCδ?, 1,   PKCδ↓, 3,   PKCδ↑, 1,   PTEN↓, 1,   PTEN↑, 1,   RAS↓, 1,   STAT3↓, 3,   STAT3↑, 3,   STAT3↝, 1,   p‑STAT3↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 4,   ATF2↑, 1,   ATF4↓, 2,   p‑cMyc↑, 1,   FOXO3↑, 1,   HDAC↓, 3,   HDAC↑, 1,   HDAC3↓, 1,   HOTAIR↑, 1,   other?, 1,   other↓, 3,   other↑, 5,   other↝, 5,   tumCV↓, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↓, 2,   p‑eIF2α↓, 1,   ER Stress↓, 4,   GRP78/BiP↓, 1,   HSP70/HSPA5↓, 1,   XBP-1↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

Beclin-1/ATG6↓, 2,   Beclin-1/ATG6↑, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 1,   LC3II↓, 1,   LC3II↑, 1,   p62↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 9,   DNArepair↑, 2,   P53↓, 4,   PARP1↓, 1,   PCNA↓, 3,   Telomerase↓, 1,   TOP1↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK2↓, 1,   CDK4↓, 1,   cycD1/CCND1↓, 1,   cycE/CCNE↓, 1,   E2Fs↑, 1,   GADD34↓, 1,   GADD45A↑, 1,   Ki-67↓, 1,   P21↓, 1,   RB1↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

CEBPA↓, 1,   HH↓, 1,   IGF-1↓, 1,   IGF-1↑, 1,   IGFBP3↑, 1,   Ki-67↓, 1,   p300↓, 1,   TumCP↓, 1,  

Migration(tgid=13) ⓘ

AntiAg↓, 2,   AntiAg↑, 10,   AP-1↓, 3,   Ca+2↓, 3,   Ca+2↝, 2,   Cartilage↑, 1,   COL1↓, 1,   E-cadherin↑, 1,   EMT↓, 1,   EMT↑, 1,   LRP1↑, 1,   MLC2/MYL9↝, 1,   MMP13↓, 1,   MMP2↓, 2,   MMP3↓, 1,   MMP9↓, 2,   MUC1↑, 1,   TGF-β↓, 2,   TGF-β↑, 2,   TGF-β1↓, 1,   TregCell↑, 1,   TumCI↓, 1,   TumCMig↓, 1,   uPA↑, 1,   Vim↓, 1,   α-SMA↓, 2,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 1,   angioG↑, 1,   HIF-1↓, 1,   Hif1a↓, 2,   Hif1a↑, 2,   NO↓, 9,   NO↑, 2,   VCAM-1↓, 3,   VEGF↓, 1,   VEGF↑, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↓, 1,   BBB↑, 13,   EPR↑, 1,   GastroP↑, 2,   GLUT4↑, 1,   H+/K+-ATPase↓, 1,   IBI↑, 2,   memfluid↑, 1,   MMP↓, 1,   MMP↑, 5,   MMP∅, 1,   OCLN↝, 1,   TJ↑, 1,   TRPC1↓, 1,   TRPV1↑, 1,   VGSC↓, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD25+↑, 1,   CD4+↑, 2,   CD8+↑, 2,   COX1↓, 4,   COX2/PTGS2↓, 23,   COX2/PTGS2↑, 1,   FOXP3↑, 1,   HMGB1↓, 2,   ICAM-1↓, 2,   IFN-γ↓, 5,   IFN-γ↑, 1,   IL1?, 1,   IL1↓, 1,   IL10↓, 3,   IL10↑, 8,   IL17↓, 5,   IL18↓, 2,   IL1β↓, 21,   IL2↓, 1,   IL23↓, 1,   IL4↓, 3,   IL4↑, 2,   IL6?, 2,   IL6↓, 34,   IL8↓, 3,   Imm↓, 1,   Imm↑, 9,   Imm↝, 1,   Inflam?, 2,   Inflam↓, 121,   Inflam↑, 1,   LPS↓, 2,   M2 MC↑, 1,   pol-M2 MC↑, 1,   MCP1/CCL2↓, 5,   MyD88↓, 1,   NeuroI↓, 1,   NF-kB↓, 36,   NF-kB↑, 1,   NLRP3↓, 6,   NLRP3↑, 1,   PGE2↓, 7,   PGE2↑, 1,   RAGE↓, 2,   SOCS-3↓, 1,   Th1 response↓, 1,   Th2↑, 2,   TLR4↓, 4,   TLR4↑, 1,   TNF-α?, 1,   TNF-α↓, 42,   Treg lymp↝, 1,   TRIF↓, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↑, 1,   AChE↓, 11,   BChE↓, 2,   BDNF↓, 1,   BDNF↑, 7,   GABA↑, 3,   MAOA↓, 4,   MAOB↓, 1,   NGF↑, 1,   TrkB↑, 1,  

Protein Aggregation(tgid=19) ⓘ

AGEs↓, 3,   APP↓, 1,   Aβ↓, 18,   Aβ42↓, 1,   BACE/β-secretase↓, 3,   tau↓, 4,   p‑tau↓, 2,   β-Amyloid↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

ACE/ACE1↓, 1,   ACE2↓, 1,   AHR↓, 1,   BNP↓, 1,   CYP19↓, 1,   Estro↓, 1,   GR↑, 1,   PPARα↑, 1,   PPARα↝, 1,   PPARγ↓, 1,   p‑PPARγ↓, 1,   testos↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv?, 1,   BioAv↓, 44,   BioAv↑, 50,   BioAv⇅, 1,   BioAv↝, 32,   BioEnh↑, 1,   ChemoSen↑, 5,   CompStab↑, 2,   CompStab↝, 2,   Dose?, 1,   Dose↓, 1,   Dose↑, 4,   Dose↝, 21,   eff↑, 18,   eff↝, 1,   GSTA1↓, 1,   GSTA1↑, 1,   Half-Life↓, 4,   Half-Life↑, 1,   Half-Life↝, 14,   Half-Life∅, 1,   P450↓, 1,   P450↑, 1,   selectivity↑, 3,   Synergy↑, 15,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 14,   ALP↓, 3,   anemia↓, 1,   AST↓, 16,   BG↓, 2,   BloodF↑, 1,   BMD↑, 2,   BP↓, 7,   BUN?, 1,   BUN↓, 1,   CK/CK-MB↓, 1,   creat↓, 4,   CRP↓, 5,   Ferritin↓, 1,   HemoG↑, 1,   HOMA↓, 1,   hs-CRP↓, 2,   IL6?, 2,   IL6↓, 34,   IRes↝, 1,   LDH↓, 4,   LDH↑, 1,   NOS2↓, 2,   RAGE↓, 2,   RBC↑, 1,   SpO2↑, 1,   TC↓, 2,   TG/TAG↓, 1,   TMAO↓, 1,   Urea↓, 1,  

Functional Outcomes(tgid=23) ⓘ

Analgesic↑, 4,   AntiAge↑, 6,   antiAll↑, 15,   AntiArt↑, 10,   AntiCan↓, 2,   AntiCan↑, 23,   AntiDiabetic↑, 29,   antiPs↑, 2,   AntiTum↓, 1,   AntiTum↑, 3,   cardioP?, 2,   cardioP↑, 46,   cardioP⇅, 1,   CardioT↓, 2,   chemoP↑, 16,   chemoPv↑, 10,   cognitive↓, 1,   cognitive↑, 18,   cough?, 1,   diuretic↑, 1,   hepatoP↓, 1,   hepatoP↑, 46,   Learn↑, 1,   memory?, 1,   memory↑, 15,   motorD↓, 1,   motorD↑, 1,   Mucositis↓, 1,   neuroP↓, 1,   neuroP↑, 68,   Obesity↓, 12,   OS↑, 3,   Pain↓, 5,   QoL↑, 1,   radioP↑, 7,   RenoP↑, 10,   Risk↓, 2,   Sleep↑, 1,   SoreThr?, 1,   Strength↑, 1,   Stress↓, 1,   Stroke↓, 8,   toxicity?, 1,   toxicity↓, 49,   toxicity↑, 4,   toxicity↝, 18,   toxicity∅, 9,   Weight↓, 1,   Weight↑, 1,   Wound Healing↑, 5,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 6,   AntiFungal↑, 3,   AntiP↑, 1,   AntiViral↑, 11,   Bacteria↓, 26,   Diar↓, 2,   GutMicro↑, 19,   Sepsis↓, 2,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr?, 1,   Ingr↑, 4,   Ingr↝, 7,  
Total Targets: 465

Scientific Paper Hit Count for: ChemoSen, chemo-sensitization
53 Cisplatin
40 Chemotherapy
39 doxorubicin
31 Curcumin
20 Magnetic Fields
20 Thymoquinone
18 Resveratrol
17 5-fluorouracil
16 Sulforaphane (mainly Broccoli)
15 Luteolin
15 Quercetin
13 Apigenin (mainly Parsley)
13 Docetaxel
13 Artemisinin
13 Baicalein
13 Betulinic acid
13 Chrysin
13 Eugenol
13 Lycopene
12 Radiotherapy/Radiation
12 Fisetin
12 Kaempferol
12 Melatonin
12 Morin
11 Propolis -bee glue
11 Capsaicin
11 Paclitaxel/Taxol
11 Gambogic Acid
11 Honokiol
10 Vitamin C (Ascorbic Acid)
10 diet FMD Fasting Mimicking Diet
10 diet Methionine-Restricted Diet
10 Ivermectin
9 Citric Acid
9 Metformin
9 EGCG (Epigallocatechin Gallate)
9 Flaxseed/Linseed
9 phytic acid, Inositol hexakisphosphate
8 Sorafenib (brand name Nexavar)
8 Silver-NanoParticles
8 Copper and Cu NanoParticles
8 Ashwagandha(Withaferin A)
8 brusatol
8 Boswellia (frankincense)
8 Selenium NanoParticles
8 salinomycin
8 Formononetin
8 Matrine
8 Shikonin
7 Astragalus
7 Berberine
7 Disulfiram
7 Emodin
7 Pterostilbene
7 Selenite (Sodium)
7 Vitamin K2
6 Allicin (mainly Garlic)
6 Selenium
6 Gemcitabine (Gemzar)
6 borneol
6 chitosan
6 Fucoidan
6 Linalool
6 Magnolol
6 methylseleninic acid
6 Phenethyl isothiocyanate
6 Piperlongumine
6 Rosmarinic acid
5 2-DeoxyGlucose
5 Anti-oxidants
5 Astaxanthin
5 Atorvastatin
5 Beta-Caryophyllene
5 Cinnamon
5 Coenzyme Q10
5 Crocetin
5 Docosahexaenoic Acid
5 diet Short Term Fasting
5 Indole-3-carbinol
5 Hydrogen Gas
5 Hyperthermia
5 Inositol
5 itraconazole
5 VitK3,menadione
5 Urolithin
4 Alpha-Lipoic-Acid
4 Berbamine
4 Caffeic acid
4 Caffeic Acid Phenethyl Ester (CAPE)
4 Chlorogenic acid
4 Cucurbitacin
4 Dichloroacetate
4 Oxygen, Hyperbaric
4 Dandelion Root
4 Ellagic acid
4 tamoxifen
4 isoorientin
4 low dose naltrexone
4 mebendazole
4 Bicarbonate(Sodium)
4 Phenylbutyrate
3 3-bromopyruvate
3 Auranofin
3 Andrographis
3 Isovitexin
3 beta-glucans
3 immunotherapy
3 Baicalin
3 Brucea javanica
3 Boron
3 Trastuzumab
3 Piperine
3 NTP, Non-Thermal Plasma,Cold Atmospheric Plasma
3 Carvacrol
3 carboplatin
3 Celastrol
3 Chlorophyllin
3 Hydroxycinnamic-acid
3 Electrical Pulses
3 Gallic acid
3 Garcinol
3 Ginkgetin
3 Gossypol/AT-101
3 HydroxyCitric Acid
3 isoflavones
3 Methylsulfonylmethane
3 Silymarin (Milk Thistle) silibinin
2 Phyllanthus emblica/Emblica officinalis/Amla / Indian Gooseberry
2 Anethole/trans-Anethole
2 Dipyridamole
2 Biochanin A
2 Bromelain
2 erastin
2 Bortezomib
2 Carnosic acid
2 capecitabine
2 Thymol-Thymus vulgaris
2 Cat’s Claw
2 Cannabidiol
2 chemodynamic therapy
2 Celecoxib
2 Folic Acid, Vit B9
2 Calorie Restriction Mimetics
2 Carvone
2 Cynaropicrin
2 Diclofenac
2 Diindolylmethane
2 D-limonene
2 Lemongrass Extract/Citral
2 Exercise
2 Flaxseed Oil
2 Shilajit/Fulvic Acid
2 Ginkgo biloba
2 Genistein (soy isoflavone)
2 Geraniol
2 Ginkgolide B
2 Ginseng
2 Spermidine
2 iodine
2 Isoliquiritigenin
2 Recombinant Methioninase
2 Licorice
2 SDG/lignans
2 Lutein
2 Methyl Jasmonate
2 Mushroom Lion’s Mane, Hericium erinaceus
2 Naringin
2 Niclosamide (Niclocide)
2 Plumbagin
2 Psoralidin
2 Rutin
2 Oxaliplatin
2 Terpinen-4-ol / Tea Tree Oil
1 Gold NanoParticles
1 Photodynamic Therapy
1 Amodiaquine
1 Vitamin A, Retinoic Acid
1 temozolomide
1 Aspirin
1 Aloe anthraquinones
1 epirubicin
1 Lapatinib
1 Ras-selective lethal 3
1 Butyrate
1 urea
1 Centella asiatica / Gotu kola → asiaticoside
1 Vitamin E
1 Cynara scolymus/Globe Artichoke/Artichoke Extract
1 Cyclopamine
1 Deguelin
1 diet Ketogenic
1 Zinc
1 Echinacea
1 Ginkgo biloba-EGb 761
1 Eurycomanone
1 Evodiamine
1 Ferulic acid
1 Fenbendazole
1 Ginkgolic acids
1 Ginger/6-Shogaol/Gingerol
1 γ-linolenic acid (Borage Oil)
1 Graviola
1 hydrogen sulfide
1 Hibiscus sabdariffa
1 HydroxyTyrosol
1 Hyperoside
1 MCT, metronomic chemo
1 Licochalcone A
1 Lactoferrin/Talactoferrin
1 Bevacizumab (brand Avastin)
1 Dordaviprone; Modeyso
1 Modified Citrus Pectin
1 vp16, etoposide
1 Magnetic Field Rotating
1 Methylglyoxal
1 Moringa oleifera
1 Lemon Balm/Melissa officinalis
1 Mucuna pruriens/Velvet Bean
1 Mistletoe/Viscum album Extracts
1 Mushroom Chaga, Inonotus obliquus
1 Mushroom Reishi
1 Nimbolide
1 nelfinavir/Viracept
1 Proanthocyanidins
1 SonoDynamic Therapy UltraSound
1 Propyl gallate
1 Ramucirumab (CYRAMZA)
1 Rhein
1 buckwheat sprouts
1 Sulfasalazine
1 irinotecan
1 cetuximab
1 Aflavin-3,3′-digallate
1 Vitamin D3
1 Vitexin
1 Wogonin
1 Zerumbone
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:1106  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page